Fatal opiate overdose following regimen changes in naltrexone treatment [1]

Addiction

Volumn 100, Issue 4, 2005, Pages 560-561

  Oliver, Phillip ^a   Horspool, Michelle ^b   Keen, Jenny ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; MORPHINE; NALTREXONE; OPIATE;

CASE REPORT; DEATH; DRUG DEPENDENCE; DRUG FATALITY; DRUG FORMULATION; DRUG IMPLANT; DRUG OVERDOSE; DRUG TOLERANCE; DRUG WITHDRAWAL; HEROIN DEPENDENCE; HUMAN; INFECTION; LETTER; PRESCRIPTION; RELAPSE; SUICIDE; UNITED KINGDOM;

DRUG IMPLANTS; FATAL OUTCOME; HUMANS; INFUSION PUMPS, IMPLANTABLE; NALTREXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; OVERDOSE;

EID: 17244378767     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2005.01020.x     Document Type: Letter

References (4)

1. Miotto, K., McCann, M. J., Rawson, R. A., Frosch, D. & Ling, W. (1997) Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts. Drug and Alcohol Dependence, 45, 131-134.
2. Foster, J., Brewer, C. & Steele, T. (2003) Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels. Addiction Biology, 8, 211-217.
3. Brewer, C. (2002) Serum naltrexone and 6-beta-naltrexol levels from naltrexone implants can block very large amounts of heroin: a report of two cases. Addiction Biology, 7, 321-323.
4. White, J. M. & Irvine, R. J. (1999) Mechanisms of fatal opioid overdose. Addiction, 94, 961-972.